LINC00261 expression reduces mutation accumulation while conferring resistance to cisplatin and altering the tumor-immune microenvironment in lung adenocarcinoma
J. Castillo, T. Xue, S. Joseph, M. Norwood, D. J. Mullen, S. Berrellez, S. James, A. L. Epstein, T. McEachron, C. N. Marconett
This study identifies LINC00261 as a gene that reduces mutation accumulation, confers cisplatin resistance, and alters the tumor-immune microenvironment in lung adenocarcinoma.
bioRxiv · Mar 2, 2023 · PreprintCancer Biology